Search Results
Aug 11, 2026, 08:00 ET Kalohexis Appoints Life Sciences Leader, Jeffrey Sherman, MD, to Board of Directors
system to shape the next era of metabolic disease care starting with obesity and cancer cachexia, today announced the appointment of Jeffrey Sherman, MD, FACP, to its Board of Directors.
More news about: Kalohexis
Aug 11, 2026, 08:00 ET YourMenu Named to the Inc. 5000 for the Second Consecutive Year
America's fastest-growing private companies, ranking No. 1862 on the 2026 Inc. 5000 list.FREDERICK, Md., Aug. 11, 2026 /PRNewswire/ -- YourMenu, a leading restaurant technology platform helping independent restaurants
More news about: YourMenu
Aug 11, 2026, 07:54 ET EQT Life Sciences participates in Vaderis Therapeutics' USD 152 million Series B financing
team as they advance engasertib into Phase 3 with the goal of potentially bringing these patients their first dedicated therapy."Azmi Nabulsi, MD, MPH, President and Chief Executive Officer of Vaderis Therapeutics, said: "Today represents a defining moment for HHT patients. Closing this financing
More news about: EQT
Aug 11, 2026, 07:00 ET Vaderis Therapeutics Announces Oversubscribed $152 Million Series B Financing and Initiation of the Global Phase 3 HEROIC Study of Engasertib for Hereditary Hemorrhagic Telangiectasia
to address the significant unmet needs of patients living with HHT."Today represents a defining moment for HHT patients," said Azmi Nabulsi, MD, MPH, President and Chief Executive Officer of Vaderis Therapeutics. "Closing this financing and initiating HEROIC as the first Phase 3 study utilizing
More news about: Vaderis Therapeutics AG
Aug 11, 2026, 07:00 ET Vaderis Therapeutics Announces Oversubscribed $152 Million Series B Financing and Initiation of the Global Phase 3 HEROIC Study of Engasertib for Hereditary Hemorrhagic Telangiectasia
to address the significant unmet needs of patients living with HHT."Today represents a defining moment for HHT patients," said Azmi Nabulsi, MD, MPH, President and Chief Executive Officer of Vaderis Therapeutics. "Closing this financing and initiating HEROIC as the first Phase 3 study utilizing
More news about: Vaderis Therapeutics AG
Aug 11, 2026, 07:00 ET RazorMetrics Named to Inc. 5000 Fastest-Growing Companies List for Second Consecutive Year
both the urgency of the prescription affordability challenge and the market's response to a model designed to address it earlier," said Siva Mohan, MD, co-founder, president, and chief medical officer of RazorMetrics. "RazorMetrics was built to identify avoidable medication spend in the prescription
More news about: RazorMetrics
Aug 11, 2026, 05:59 ET Medality Launches Job Board Connecting Employers with Radiology's Most Engaged Talent Network
thinking about where their career goes next.""Finding the right radiologist is about more than filling an open position," said Akshay Gupta, MD, Neuroradiologist at Radiology Associates, P.C. in Eugene, OR. "It's about identifying physicians who are a strong clinical and cultural fit for our practice
More news about: TrueLearn
Aug 11, 2026, 02:00 ET Blue Shield of California nombra al Dr. Kedar S. Mate, líder en innovación sanitaria, miembro de su consejo de administración
11 de agosto de 2026 /PRNewswire-HISPANIC PR WIRE/ -- Blue Shield of California ha anunciado hoy el nombramiento de Kedar S. Mate, MD, médico, líder en calidad asistencial y director médico de Qualified Health AI, como miembro del Consejo de Administración de esta aseguradora sanitaria
More news about: Blue Shield of California
Aug 10, 2026, 18:22 ET SILVERCORP REPORTS ADJUSTED NET INCOME OF $53.9 MILLION, $0.24 PER SHARE, AND CASH FLOW FROM OPERATING ACTIVITIES OF $61.7 MILLION FOR Q1 FISCAL 2027
PERFORMANCE (NON-GAAP) MEASURESThis news release should be read in conjunction with the Company's Management Discussion & Analysis ("MD&A"), the unaudited consolidated condensed interim financial statements and related notes contains therein for the three months ended June 30, 2026, which
More news about: Silvercorp Metals Inc.
Aug 10, 2026, 16:22 ET In HelloNation Bathroom Remodeling Expert Josh Martinez Outlines Tub to Shower Conversion Planning
GAITHERSBURG, Md., Aug. 10, 2026 /PRNewswire/ -- What should homeowners expect when planning a tub to shower conversion in the DC suburbs? That question is the focus of a
More news about: HelloNation
Aug 10, 2026, 15:03 ET The Inner Circle acknowledges Alfredo Nudman, MD as a Pinnacle Lifetime Member
2026 /PRNewswire/ -- Prominently featured in The Inner Circle, Alfredo Nudman, MD is acknowledged as a Pinnacle Lifetime Member for his contributions to Psychiatry and Advanced Mental Health Treatment. Alfredo Nudman, MD has built a distinguished career in psychiatry and mental health care, recognized
More news about: The Inner Circle
Aug 10, 2026, 15:00 ET Board-Certified Plastic Surgeon Dr. Michael Byun Introduces Anatomy-Based Approach That Extends Beyond the Traditional Deep Plane Facelift
Dr. Michael Byun, MD is an American Board of Plastic Surgery–certified plastic surgeon and founder of Chicago Cosmetic Surgery. A graduate of Northwestern University
More news about: Chicago Cosmetic Surgery
Aug 10, 2026, 14:51 ET Nadia Ovchinsky, MD, Appointed Chair of Pediatrics at NYU Langone Health
Nadia Ovchinsky, MD, an internationally recognized pediatric hepatologist, as the Pat and John Rosenwald Professor of Pediatrics and chair of the
More news about: NYU Langone Health
Aug 10, 2026, 14:46 ET Wholeness Center Brings 16 Years of Integrative Psychiatry to a New Adult Dual Diagnosis IOP
while remaining within the same clinical philosophy and care team."Collaborative care is the cornerstone of how we work. " said Scott Shannon, MD, co-founder of Wholeness Center. "From assessment to treatment, we collaborate with patients as well as our other providers to eliminate silos and open
More news about: The Wholeness Center
Aug 10, 2026, 14:45 ET Society for Immunotherapy of Cancer Forward Fund Announces 2026 Fellowship Recipients, Awarding $150,000 to Support the Next Generation of Cancer Immunotherapy Researchers
in cancer immunotherapy begins with researchers willing to ask bold questions and pursue new possibilities," said SITC Vice President Sandra Demaria, MD. "By investing in exceptional early career investigators, the Forward Fund is helping build the scientific foundation for tomorrow's breakthroughs.
More news about: Society for Immunotherapy of Cancer (SITC)
Aug 10, 2026, 14:15 ET Employ Prince George's Welcomes Nona Carroll as Chief Program Impact Officer
Workforce Development Leader Joins Executive Team to Advance Strategic Programs and Community ImpactLARGO, Md., Aug. 10, 2026 /PRNewswire/ -- Employ Prince George's, Inc. (EPG) today announced the appointment of Nona Carroll
More news about: Employ Prince George's
Aug 10, 2026, 12:31 ET Blue Shield of California Appoints Healthcare Innovation Leader Kedar S. Mate, MD, to Board of Directors
Calif., Aug. 10, 2026 /PRNewswire/ -- Blue Shield of California today announced the appointment of Kedar S. Mate, MD, a physician, healthcare quality leader, and chief medical officer of Qualified Health AI, to the nonprofit health plan's Board of Directors. Dr. Mate
More news about: Blue Shield of California
Aug 10, 2026, 12:11 ET LODE GOLD RECEIVES THREE-YEAR DRILL PERMIT AT FLAGSHIP FREMONT GOLD MINE, CALIFORNIA
the Company with securities regulators, including those described under the heading "Risks and Uncertainties" in the Company's most recently filed MD&A. The Company does not undertake to update or revise any forward-looking statements, except in accordance with applicable law.
More news about: Lode Gold Resources Inc
Aug 10, 2026, 11:15 ET ASCP Names Alexandra Brown, MD, FASCP, as Chief Executive Officer
Aug. 10, 2026 /PRNewswire/ -- The American Society for Clinical Pathology (ASCP) today announced the appointment of Alexandra Brown, MD, FASCP, as its Chief Executive Officer, following her successful tenure as Interim CEO over the past year. The selection was made after a national search
More news about: American Society for Clinical Pathology
Aug 10, 2026, 10:16 ET QuadMed Makes Connecting to Care as Simple as a Text
bandwidth to focus on patient care."At QuadMed, convenience should never come at the expense of patient privacy," said Kathryn Quadracci Flores, MD, CEO of QuadMed. "Text messaging is familiar and accessible, but standard SMS is not designed for confidential clinical communication. We use it for limited,
More news about: QuadMed
Aug 10, 2026, 09:50 ET THE LUSTGARTEN FOUNDATION AND BREAK THROUGH CANCER ANNOUNCE NEW CLINICAL TRIAL EVALUATING KRAS-TARGETED IMMUNOTHERAPY STRATEGY FOR PANCREATIC CANCER
Led by Kevin Soares, MD, and Eileen O'Reilly, MD, Memorial Sloan Kettering Cancer Center, the multi-institutional study will evaluate the investigational therapy ELI-002 7P, from Elicio
More news about: Lustgarten Foundation
Aug 10, 2026, 09:40 ET AQUAPASS Completes Enrollment in REFORM-HF Pivotal Trial, Results to Be Presented at Major Heart Failure Conference This Fall
https://clinicaltrials.gov/study/NCT06360380#contacts-and-locations "This is a major milestone for AQUAPASS and for the patients we aim to serve," said Noam Josephy, MD, MSc, MBA, Chief Executive Officer of AQUAPASS. "We're now focused on completing our data analysis, preparing for presentation and publication, and advancing
More news about: AQUAPASS, Inc.
Aug 10, 2026, 09:24 ET Florida Cancer Specialists & Research Institute Welcomes Neel K. Gakhar, MD
Florida Cancer Specialists & Research Institute, LLC (FCS) welcomes board-certified medical oncologist and hematologist Neel K. Gakhar, MD, to the statewide practice. Dr. Gakhar will provide care to patients at the FCS clinics in
More news about: Florida Cancer Specialists & Research Institute
Aug 10, 2026, 09:15 ET Abbott Lanza una Campaña en Español con Gabriela Spanic para Fomentar la Detección del Cáncer de Colon con Cologuard Plus®
AB, Rutter CM, Peterse EFP, et al. Colorectal Cancer Screening: An Updated Decision Analysis for the U.S. Preventive Services Task Force. Rockville (MD): Agency for Healthcare Research and Quality (US); May 2021.
More news about: Abbott
Aug 10, 2026, 09:00 ET Choice Hotel International's Cambria® Hotels Continues Expansion with New Openings in Texas and Oregon
brand's footprint in high-demand destinations as the company's upscale momentum continues NORTH BETHESDA, Md., Aug. 10, 2026 /PRNewswire/ -- Cambria® Hotels, an upscale brand of Choice Hotels International, Inc. (NYSE:
More news about: Choice Hotels International, Inc.